JCI - Oncogenic KRAS signaling drives evasion of innate immune surveillance in lung adenocarcinoma by activating CD47
Targeting CD47/TNFAIP8 by miR-155 overcomes drug resistance and inhibits tumor growth through induction of phagocytosis and apoptosis in multiple myeloma | Haematologica
CD47 and thrombospondin-1 regulation of mitochondria, metabolism, and diabetes | American Journal of Physiology-Cell Physiology
SIRPα–CD47 Immune Checkpoint Blockade in Anticancer Therapy: Trends in Immunology
CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis | Nature
Frontiers | Targeting CD47 as a Novel Immunotherapy for Breast Cancer
CD47: role in the immune system and application to cancer therapy | Cellular Oncology
Cells | Free Full-Text | Targeting the CD47-SIRPα Axis: Present Therapies and the Future for Cutaneous T-cell Lymphoma
Regulation of CD47 expression in cancer cells - ScienceDirect
CD47 — Wikipédia
Vaccines | Free Full-Text | Anti-CD47 Monoclonal Antibody–Drug Conjugate: A Targeted Therapy to Treat Triple-Negative Breast Cancers
063CE: Anti-CD47 Testing Interference with Connie Westhoff -
CD47: the next checkpoint target for cancer immunotherapy - ScienceDirect
Role of CD47 in Hematological Malignancies | Journal of Hematology & Oncology | Full Text
CD47‐signal regulatory protein α signaling system and its application to cancer immunotherapy - Murata - 2018 - Cancer Science - Wiley Online Library
CD47-related Signaling Pathways & Research Progress on the Relationship with Related Diseases (Part Two) – Creative Biolabs Blog
Targeting the CD47/SIRPɑ Axis in Cancer Immunotherapy
Frontiers | Therapeutic Targeting of the Macrophage Immune Checkpoint CD47 in Myeloid Malignancies
Role of CD47 in Hematological Malignancies | Journal of Hematology & Oncology | Full Text
2021 Jeffrey M. Hoeg Award Lecture: Defining the Role of Efferocytosis in Cardiovascular Disease: A Focus on the CD47 (Cluster of Differentiation 47) Axis | Arteriosclerosis, Thrombosis, and Vascular Biology
Second “Don't Eat Me” Signal Identified in Cancer Cells, Points to New Immunotherapies | The Stem Cellar
Monoclonal anti‐CD47 interference in red cell and platelet testing - Velliquette - 2019 - Transfusion - Wiley Online Library
CD47/SIRP alpha biochemical HTRF binding assay | Cisbio
Targeting CD47 for cancer immunotherapy | Journal of Hematology & Oncology | Full Text
